ADORAL® SEMA

Oral Form of semaglutide, a GLP-1 receptor agonist

  1. Home
  2. >
  3. Products
  4. >
  5. AdOral® Sema

ADORAL® SEMA

AdOral Sema is an orally administered glucagon-like peptide 1 (GLP-1) receptor agonist: semaglutide. Semaglutide is approved as a treatment of type 2 diabetes to improve glycemic control. It is also approved for weight loss and weight maintenance.

Adocia has applied its AdOral® technology to switch the administration route of semaglutide from injectable to oral.

Preclinical results show that AdOral® Sema has a significantly improved absorption.

Preclinical results – Median pharmacokinetic profile of oral semaglutide in dogs over five hours after administration (n=10)

Formulation of semaglutide with AdOral technology demonstrates at least a five-fold higher bioavailability compared to Rybelsus®.

AdOral technology opens up numerous applications for oral formulation of peptides.

AdOral® Sema is available for

partnering

Other products

BioChaperone® GLP-1 Amylin

Designed to improve obesity drugs through peptide co-formulation

BioChaperone® Lispro

Best-in-class ultra-rapid acting insulin for a tighter glycemic control

BioChaperone® Combo

The best insulin premix

AdoShell® Islets

Immunoprotective scaffold for pancreatic islet transplant

M1Pram

A breakthrough treatment to address the unmet medical needs of overweight or obese people under intensive insulin therapy

BioChaperone® LisPram

A breakthrough treatment to address the unmet medical needs of overweight patients under intensive insulin therapy – optimized for administration via insulin pump

AdoGel® Sema

Long-Acting Injectable

Pipeline

Adocia announces the successful completion of its capital increase.

Access detailed information about this transaction.

The following pages contain data related to Adocia’s capital increase. For regulatory reasons, access to this content is restricted. We therefore invite you to complete the fields below in order to view this content.

Learn more

Adocia annonce la réussite de son opération d’augmentation de capital.

Accédez aux informations détaillées concernant cette opération.

Les pages suivantes présentent des données liées à l’augmentation de capital d’Adocia. Pour des raisons réglementaires, l’accès à ce contenu est limité. Nous vous invitons donc à compléter les champs ci-dessous afin de pouvoir consulter ce contenu.

En savoir plus